AKUNNA UKANWOKE: Open Payments
NPI 1053724591 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 83 payments from 11 companies in 2025. Trend: 2023 $1,387 · 2024 $2,058 · 2025 $2,119
Food & beverage: $2,119
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 14 | $493 |
| Madrigal Pharmaceuticals | 15 | $420 |
| Gilead Sciences, Inc. | 17 | $396 |
| ABBVIE INC. | 15 | $276 |
| Novo Nordisk Inc | 4 | $171 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $160 |
| Intercept Pharmaceuticals, Inc. | 5 | $83 |
| Mirum Pharmaceuticals, Inc. | 3 | $55 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: IQIRVO, REZDIFFRA, MAVYRET, Wegovy, XIFAXAN, OCALIVA, Livmarli, TERLIVAZ.
Industry payments across TX — which companies pay providers there.
